#QuantumVillage Viva Technology #VivaTech Very happy to continue our pitch session with Sarada Loock from Qubit Pharmaceuticals She explains that Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. #quantumComputing Neil Abroug Sabine Mehr Stephane Requena Philippe LAVOCAT Félix Givois Gwladys Texier Jonah JAUBERT Annabel Truong Nicolas Belot GENCI
HQI France’s Post
More Relevant Posts
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dNsHSDYW The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
Great to see #Ariceum profiled in the Spring Edition of European Biotechnology - Life Science and Industry Magazine (EBM). Read the interesting article, which explores the evolving developments in the #radiopharmaceutical space and highlights the increasing interest from investors and big pharma. Our CEO, Manfred Ruediger, and CMO, Germo Gericke, provided insights and compared the current state of the radiopharmaceuticals field with the course that checkpoint inhibitors took and their initial successes which in turn have led to a wave of imitators and the emergence of today's state of play. Article source: European Biotech News! #lifesciences #biotech #radiopharmaceuticals #satoreotide #ATT001
To view or add a comment, sign in
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dkdWMzY5 The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/d7NxaUjd The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dBM4MeP3 The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
As a CMC leader also supporting marketing at WuXi XDC, I’d like to share this news again which was posted by WuXi XDC’s own new LinkedIn account. WuXi XDC is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market. It provides end-to-end contract research, development and manufacturing services for bioconjugates, including ADCs. Its services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. WuXi XDC and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, have reached a comprehensive partnership in drug-linker technology, which is co-developed with HySlink Therapeutics (“HySlink”), and CRDMO services spanning from discovery to commercialization. I’d like to take this opportunity to invite you to follow WuXi XDC’s LinkedIn account right NOW. #adc #adcs #antibodydrugconjugates #cdmo #crdmo #collaborations #partnership #partnerships
We are excited to announce that WuXi XDC, a leading global CRDMO focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, have reached a comprehensive partnership in drug-linker technology, which is co-developed with HySlink Therapeutics (“HySlink”), and CRDMO services spanning from discovery to commercialization. Both parties will synergize their strengths to speed up discovery and development of advanced ADCs by offering the novel T-moiety linker, Exatecan as payload, as well as an integrated discovery and development services. This platformization of new technologies will enable our clients to accelerate selection of an ADC lead at the discovery stage and bring the ADC product quickly from discovery to clinical trials. Read more: https://lnkd.in/dePH9G6j #WuXiXDC #CRDMO #ADC #Bioconjugate #Platform #Parntership
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dz9Z8nXf The speakers Celestine Chi(AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
👨🔬 👩🔬 Large and small molecule-based drug discovery will be in the spotlight at a pair of symposia in Europe this week! ⏩ With the theme 'Unlocking High-throughput Biology in Drug Discovery' the meetings in Oxford and Utrecht are organised by Carterra and industry partners Large molecules Amongst the exciting agenda of presentations from academic and industry researchers, look out for two new application notes developed by scientists from Bio-Techne's protein sciences team leveraging the Carterra LSA's capabilities for high-throughput biophysical characterisation: 🛠 Comparing recombinantly engineered biosimilar antibodies with originator therapeutic antibodies 🏎 Acceleratating antibody pair screening for immunoassay applications Small molecules We're also excited to have been collaborating with the Carterra applications team, who will highlight capabilities for high-throughput SPR based small-molecule drug discovery applications, using tools developed by Bio-Techne chemists: 🎯 Targeted protein degradation 🛑 Kinase inhibitors #drugdiscovery
Join Carterra and our co-hosts in Europe at our upcoming symposia on 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗮𝗻𝗱 𝘀𝗺𝗮𝗹𝗹 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 — network with your peers! Our presenters include scientists from these industry-leading companies: GSK, University of Oxford, IPA (ImmunoPrecise Antibodies), WuXi Biologics, Ichnos Glenmark Innovation, LifeArc, BioStrand (a subsidiary of IPA), and Carterra. ✨ Register Here: https://lnkd.in/dUq45S6r #drugdiscovery #spr #smallmolecule #AI #biotechnology #antibodydiscovery
To view or add a comment, sign in
-
-
Data Scientist | Life Sciences Expert | Biophysicist | Quantitative Fluorescence Microscopist | Futurist
Supranatural... Not a common term in biophysics and biotech space, but I love it! Flagship Pioneering, can you tell us, and/or point us the literature, to give a flavor of what AI you're leaning into for this cool direction? The prefix "supra-" means "above" or "beyond." "Natural" pertains to something existing in or derived from nature. Together, "supranatural" can imply something that goes beyond the natural, often associated with extraordinary, enhanced, or superior properties compared to what is typically found in nature. "Biologics": Biologics are products derived from living organisms or contain components of living organisms, including a wide range of products such as vaccines, blood components, gene therapies, tissues, and recombinant proteins.
Flagship unveils Abiologics to pioneer supranatural biologics. The company's platform leverages generative AI and high throughput chemical protein synthesis to create Synteins™, a new class of programmable medicines that aims to redefine what therapeutics can achieve for patients. #FlagshipFounded Read the full announcement: https://bit.ly/4fdEHpy
Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics
To view or add a comment, sign in
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dxJX5nwn The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
Chief Operating Officer @ Qubit Pharmaceuticals | ex-JnJ & AstraZeneca | INSEAD MBA
3moThank you Sarada Loock for representing Qubit Pharmaceuticals ! #womeninquantum